Satellos Bioscience (TSX: MSCL:CA) appointed Wildon Farwell, M.D., MPH, as chief medical officer. Dr. Farwell joins Satellos from Dyne Therapeutics (DYN), where he most recently served as CMO and ...

Becton Dickinson’s plan to focus on medical technology advanced further after reaching a deal to divest its biosciences and diagnostic solutions business to Waters Corp. for around $17.5 billion.

Ben Lamm, CEO of Colossal Biosciences, wanted to ensure his brand was approachable to all, fun, educational and full of energy to inspire a new generation of scientists.

Colossal Biosciences plans to revive the extinct giant moa using DNA edits, sparking debate over de-extinction ethics and the ecological role of GMO animals.

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human settlers first arrived on the country’s two main islands. Now, a Texas ...

Niagen Bioscience undertakes no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances after the date of this release, except as required by law.

The roller-coaster ride for Regencell Bioscience Holdings shares continued Monday.

Regencell Bioscience (RGC) stunned the market with a jaw-dropping 120% surge in a single trading session on Thursday, despite no major news. The company has a history of wild stock swings fueled ...

Concentra Biosciences continues to scavenge for struggling biotechs, this time picking up antibody biotech IGM Biosciences for $1.25 per share.

Colossal Biosciences: 2025 TIME100 Most Influential CompaniesExtinction ain’t what it used to be. Around one-third of all existing species could vanish due to global warming by 2050 according to ...

Harvard Bioscience, a Holliston-based biotech firm, has fallen out of compliance with Nasdaq stock exchange requirements following the resignation of a board of directors member.

A rivalry between two drugmakers, Cogent Biosciences and Blueprint Medicines, has turned ugly.